Physician Profile
Charles W. Taylor, M.D. practices hematology & oncology in Tulsa, OK. Charles is a 1982 graduate of University of Oklahoma College of Medicine. Medicare claims data shows Charles provided 127,121 services to 2,734 patients. The services billed most often include injection, ferric carboxymaltose, 1 mg, low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml, and injection, pembrolizumab, 1 mg.
Summarised automatically from public NPI registry and CMS Medicare data. Not written or reviewed by this provider. Claim this profile to replace it.
Source: NPPES NPI Registry
12697 E 51ST ST
Tulsa, OK 74146
Within Hematology and Oncology generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Advanced Cancers
Blood & Lymph Disorders
Blood Cancers
Blood Disorders
Blood disorders
Bone & Soft Tissue Cancers
Digestive Cancers
Endocrine Cancers
Endocrine tumors
Gastrointestinal cancer
General oncology
Genetic Blood Disorders
Gynecologic cancer
Gynecologic Cancers
Head & Neck Cancers
Head and neck cancer
Neurologic Cancers
Oncologic emergencies
Ophthalmologic oncology
Skin cancer
Skin Cancers
Urologic Cancers
Most searched procedures
Biopsies & Diagnostics
Blood disorder care
Cancer Therapies
Cancer therapy
Cellular Therapies
Consultations
Diagnostic testing
Hematology Treatments
Imaging
Infusions
Interventional oncology
Supportive Cancer Care
Supportive cancer care
Surgical & Vascular Access
Testing & Genetics
Vascular access care
127,121 services · 2,734 patients · 25 distinct codes
| Procedure | Type | Code | Services |
|---|---|---|---|
| Insertion of needle into vein for collection of blood sample | Procedure | 36415 |
1,441 |
| Injection, ferric carboxymaltose, 1 mg | Drug given | J1439 |
15,000 |
| Injection, pembrolizumab, 1 mg | Drug given | J9271 |
11,400 |
| Injection, granisetron, extended-release, 0.1 mg | Drug given | J1627 |
9,200 |
| Injection, nivolumab, 1 mg | Drug given | J9299 |
8,640 |
| Injection, oxaliplatin, 0.5 mg | Drug given | J9263 |
8,200 |
| Injection, paclitaxel, 1 mg | Drug given | J9267 |
8,049 |
| Injection, daratumumab, 10 mg and hyaluronidase-fihj | Drug given | J9144 |
7,380 |
| Injection, fosaprepitant, 1 mg | Drug given | J1453 |
4,500 |
| Injection, azacitidine, 1 mg | Drug given | J9025 |
4,400 |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Charles W. Taylor is a cancer specialist in Tulsa, OK. That is the designation recorded for this NPI in the federal registry, where it is listed as “Hematology & Oncology”.
NPI registry
Charles W. Taylor is listed at 12697 E 51St St, Tulsa, OK 74146. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (918) 505-3200. Guide.md cannot book appointments or pass on messages — please call the office directly.
NPI registry
Charles W. Taylor's National Provider Identifier is 1003859679. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Charles W. Taylor attended University of Oklahoma College of Medicine, graduating in 1982. This comes from the CMS National Downloadable File.
CMS public data
Charles W. Taylor has 44 years experience. Calculated from a graduation year of 1982, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Charles W. Taylor performs procedures including insertion of needle into vein for collection of blood sample, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Charles W. Taylor. If this is you, claiming it is free.
Guide.md
Provider data sourced from the NPPES NPI Registry and CMS public datasets. Information is provided for reference and is not medical advice.